SEC Form 4 · accession 0001209191-17-060862
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Stuart
Officer — Chief Operating Officer
Period of report
Nov 14, 2017
Accepted (ET)
Nov 15, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 14, 2017 | M | 4,215 | $4.58 | A | 105,117 | D | |
| Common Stock | Nov 14, 2017 | F | 1,039 | $18.57 | D | 104,078 | D | |
| Common Stock | Nov 15, 2017 | G | 1,100 | $0.00 | D | 102,978 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.58 | Nov 14, 2017 | M | 4,215 | D | — | Dec 19, 2018 | Common Stock | 4,215 | 48,882 | D |
Explanation of responses
- F1This option is fully vested.